Dipanjan Pan, MS, PhD, is a recognized expert in nanomedicine, molecular imaging and drug delivery. He is presently an Associate Professor in Bioengineering and Materials Science and Engineering and Institute of Sustainability in Energy and Environment in University of Illinois, Urbana-Champaign. He holds a full faculty position with Beckman Institute for Advanced Science and Technology, University of Illinois Cancer Center and Carle Foundation Hospital. Administratively he directs the Professional Masters in Engineering Program in Bioengineering in the College of Engineering. He is also a course director for the newly founded engineering inspired medical school at the University of Illinois. His research is highly collaborative and interdisciplinary centering on the development of novel materials for biomedical applications and targeted therapies for stem-like cancer cell and phenotypically screened nanomedicine platforms. Over the years, this research has resulted in more than 100 high impact peer reviewed publications in scientific journals, numerous conference abstracts and has been supported by external funding from NIH, NSF, DoD, American Heart Association and other sources. Prof. Pan edited and co-written two books published from Taylor and Francois (ISBN-13: 978-1466572829) and Springer (ISBN-13: 978-3319335445). He holds multiple patents, several ongoing clinical trials and is the founder of three University based early start-ups. His technology has been licensed for commercial development multiple times. He serves as study section review board member for NIH, CDMRP (DoD) NSF and multiple review committee member for American Heart Association. In 2016 he received Nanomaterials Letter (NML) Researcher award and in 2017 Young Innovator Award from Cellular and Molecular Bioengineering (BMES). He is an elected fellow of Royal Society of Chemistry, a Fellow of American Heart Association and American College of Cardiology. Professor Pan is an editorial board member of Scientific Reports (Nature Publishing) and an editorial advisory board member of Molecular Pharmaceutics (ACS).